Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC132619;620;621 chr2:178800584;178800583;178800582chr2:179665311;179665310;179665309
N2AB132619;620;621 chr2:178800584;178800583;178800582chr2:179665311;179665310;179665309
N2A132619;620;621 chr2:178800584;178800583;178800582chr2:179665311;179665310;179665309
N2B132619;620;621 chr2:178800584;178800583;178800582chr2:179665311;179665310;179665309
Novex-1132619;620;621 chr2:178800584;178800583;178800582chr2:179665311;179665310;179665309
Novex-2132619;620;621 chr2:178800584;178800583;178800582chr2:179665311;179665310;179665309
Novex-3132619;620;621 chr2:178800584;178800583;178800582chr2:179665311;179665310;179665309

Information

  • RefSeq wild type amino acid: T
  • RefSeq wild type transcript codon: ACA
  • RefSeq wild type template codon: TGT
  • Domain: Ig-2
  • Domain position: 29
  • Structural Position: 43
  • Q(SASA): 0.4013
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
T/A rs1337018303 None 0.005 N 0.161 0.276 0.149567049428 gnomAD-4.0.0 1.59065E-06 None None None -0.226(TCAP) N None 0 0 None 0 2.773E-05 None 0 0 0 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
T/A 0.0729 likely_benign 0.0779 benign -0.356 Destabilizing 0.005 N 0.161 neutral N 0.427162268 None -0.226(TCAP) N
T/C 0.785 likely_pathogenic 0.8085 pathogenic -0.328 Destabilizing 0.999 D 0.583 neutral None None None 0.028(TCAP) N
T/D 0.4153 ambiguous 0.4739 ambiguous 0.121 Stabilizing 0.921 D 0.533 neutral None None None -0.242(TCAP) N
T/E 0.2622 likely_benign 0.3084 benign 0.057 Stabilizing 0.917 D 0.561 neutral None None None -0.277(TCAP) N
T/F 0.3809 ambiguous 0.4334 ambiguous -0.738 Destabilizing 0.999 D 0.682 prob.neutral None None None 0.01(TCAP) N
T/G 0.4168 ambiguous 0.4809 ambiguous -0.512 Destabilizing 0.933 D 0.615 neutral None None None -0.251(TCAP) N
T/H 0.374 ambiguous 0.4284 ambiguous -0.755 Destabilizing 0.999 D 0.685 prob.neutral None None None 0.412(TCAP) N
T/I 0.1928 likely_benign 0.2169 benign -0.062 Destabilizing 0.988 D 0.573 neutral N 0.503135383 None -0.169(TCAP) N
T/K 0.2214 likely_benign 0.2578 benign -0.482 Destabilizing 0.921 D 0.554 neutral N 0.403574354 None -0.328(TCAP) N
T/L 0.1239 likely_benign 0.1389 benign -0.062 Destabilizing 0.939 D 0.574 neutral None None None -0.169(TCAP) N
T/M 0.1107 likely_benign 0.125 benign 0.014 Stabilizing 0.999 D 0.575 neutral None None None 0.39(TCAP) N
T/N 0.1339 likely_benign 0.1496 benign -0.273 Destabilizing 0.921 D 0.512 neutral None None None -0.648(TCAP) N
T/P 0.1648 likely_benign 0.1866 benign -0.13 Destabilizing 0.947 D 0.596 neutral N 0.409422351 None -0.185(TCAP) N
T/Q 0.2095 likely_benign 0.2451 benign -0.476 Destabilizing 0.981 D 0.585 neutral None None None -0.467(TCAP) N
T/R 0.206 likely_benign 0.2453 benign -0.192 Destabilizing 0.995 D 0.591 neutral N 0.431773827 None -0.264(TCAP) N
T/S 0.1264 likely_benign 0.139 benign -0.486 Destabilizing 0.031 N 0.247 neutral N 0.477378345 None -0.575(TCAP) N
T/V 0.142 likely_benign 0.1543 benign -0.13 Destabilizing 0.917 D 0.531 neutral None None None -0.185(TCAP) N
T/W 0.8117 likely_pathogenic 0.8556 pathogenic -0.748 Destabilizing 1.0 D 0.733 prob.delet. None None None 0.129(TCAP) N
T/Y 0.4272 ambiguous 0.4887 ambiguous -0.476 Destabilizing 0.999 D 0.674 neutral None None None 0.191(TCAP) N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.